This bidirectional relationship highlights the gut microbiota as a potential contributor to treatment variability and a promising target for personalized metabolic therapies
Justin Laube, MD Medical Reviewer Justin Laube, MD, is a dual board-certified integrative and internal medicine physician, retreat leader, and healing educator with over 15 years of experience caring for patients w
If you're finding yourself reaching for an extra cup of coffee or wanting a nap at 2 PM, you're not alone
For inflammatory bowel disease, mesalamine, corticosteroids, immunomodulators (azathioprine, methotrexate), and biologics (infliximab, adalimumab, vedolizumab, ustekinumab) all have Level 1 evidence from Phase III trials with thousands of patients
Monitor Your Progress and Adjust as Needed Keep track of your progress, including your dietary intake, exercise, hydration, and how you feel overall
Other symptoms: Note down any pelvic pain, severe cramping, dizziness, or unusual fatigue